BSE: STAR - Strides Pharma Science Limited

半年間の収益性: -57.9%
配当利回り: +0.05%

プロモーションスケジュール Strides Pharma Science Limited


会社について Strides Pharma Science Limited

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.

さらに詳しく
It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

ISIN INE939A01011
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.0512
Дивиденд ао 1.14
Сайт https://www.strides.com
Цена ао 586.05
1日あたりの価格変動: 0% (586.05)
週ごとの価格変動: -5.67% (621.3)
月ごとの料金変更: -11.87% (665)
3ヶ月間の価格変動: -18.24% (716.8)
半年間の価格変動: -57.9% (1392.1)
年間の価格変動: -25.74% (789.2)
3年間の価格推移: +77.86% (329.5)
5年間の価格推移: +26.36% (463.8)
10年間の価格推移: 0% (586.05)
年初からの価格変動: -14.36% (684.3)

過小評価

名前 意味 学年
P/S 1.83 8
P/BV 3.44 5
P/E 0 0
EV/EBITDA 22.91 5
合計: 5.5

効率

名前 意味 学年
ROA, % -1.13 0
ROE, % -3.26 0
合計: 0.6667

配当金

名前 意味 学年
Div yield, % 0.0512 0.13
DSI 0.8571 8.57
合計: 1.79

義務

名前 意味 学年
Debt/EBITDA 11.07 0
合計: 5.8

成長の衝動

名前 意味 学年
収益性 Revenue, % 43.72 6
収益性 Ebitda, % -46.65 0
収益性 EPS, % -289.02 0
合計: 3.2

スーパーバイザー 役職 支払い 生年
Mr. Arun Kumar Pillai B.Com. Founder & Executive Chairperson 60M 1961 (64 年)
Mr. Badree Komandur MD & Group CEO 44M 1972 (53 年)
Ms. Manjula Ramamurthy Compliance Officer & Company Secretary N/A
Sormistha Ghosh Group General Counsel, Chief Risk Officer & Chief Sustainability Officer N/A
Mr. C. K. Sundar Executive Vice President of Operations N/A
Mr. Kevin P. Cook Senior Vice President of Strides Pharma Inc. N/A
Mr. P. V. S. Ramaraju Chief Operating Officer N/A
Mr. Aditya Arun Kumar Executive Director of Business Development & Director
Mr. Vikesh Kumar Group CFO & Chief Investor Relations Officer 1985 (40 年)
Ms. Surabhi Loshali Group Chief Human Resource Officer 1980 (45 年)

住所: India, Bengaluru, Strides House - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.strides.com